Phenotyping of Human Melanoma Cells Reveals a Unique Composition of Receptor Targets and a Subpopulation Co-Expressing ErbB4, EPO-R and NGF-R
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phenotyping of Human Melanoma Cells Reveals a Unique Composition of Receptor Targets and a Subpopulation Co-Expressing ErbB4, EPO-R and NGF-R
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 1, Pages e84417
Publisher
Public Library of Science (PLoS)
Online
2014-01-30
DOI
10.1371/journal.pone.0084417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Melanoma: New Insights and New Therapies
- (2012) Vasiliki A. Nikolaou et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Novel Immunotherapeutic Agents and Small Molecule Antagonists of Signalling Kinases for the Treatment of Metastatic Melanoma
- (2011) Nagendra Natarajan et al. DRUGS
- Erythropoietin receptor contributes to melanoma cell survival in vivo
- (2011) S M Kumar et al. ONCOGENE
- Investigations on the Usefulness of CEACAMs as Potential Imaging Targets for Molecular Imaging Purposes
- (2011) Markus Heine et al. PLoS One
- Activation-Induced Cytidine Deaminase (AID)-Associated Multigene Signature to Assess Impact of AID in Etiology of Diseases with Inflammatory Component
- (2011) Diana Mechtcheriakova et al. PLoS One
- Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized
- (2010) Elsa Quintana et al. CANCER CELL
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
- (2010) Alexander D. Boiko et al. NATURE
- Mechanism of Drug Sensitivity and Resistance in Melanoma
- (2009) Caterina La Porta CURRENT CANCER DRUG TARGETS
- BRAF Signaling and Targeted Therapies in Melanoma
- (2009) Nathalie Dhomen et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Role of Erythropoietin Receptor Expression in Malignant Melanoma
- (2009) Alireza Mirmohammadsadegh et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)
- (2009) Emelie A. Djerf et al. MELANOMA RESEARCH
- Cancer stem cells are everywhere
- (2009) NATURE MEDICINE
- HER3 Is a Determinant for Poor Prognosis in Melanoma
- (2008) M. Reschke et al. CLINICAL CANCER RESEARCH
- KIT Gene Mutations and Copy Number in Melanoma Subtypes
- (2008) C. Beadling et al. CLINICAL CANCER RESEARCH
- Melanoma-induced brain metastases
- (2008) Robert R McWilliams et al. Expert Review of Anticancer Therapy
- Integrating tumor-initiating cells into the paradigm for melanoma targeted therapy
- (2008) Keiran S.M. Smalley et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of cells initiating human melanomas
- (2008) Tobias Schatton et al. NATURE
- Efficient tumour formation by single human melanoma cells
- (2008) Elsa Quintana et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started